Skip to main page content

Uveitis II: Updates in uveitis

My Session Status

What:
Talk | Exposé
When:
13:30, domingo 18 jun 2023 (1 hour 30 minutos)
Where:
Québec City Convention Centre - Room 308 B | Salle 308 B
Theme:
Uveitis

 

Learning Objectives

At the end of this session, participants will be able to:

  • Develop a comprehensive understanding of the pathophysiology and treatment options for various types of ocular inflammatory conditions, including pars planitis, non-infectious uveitis, and ocular syphilis.
  • Gain insight into the various factors affecting clinical outcomes and long-term prognosis in patients with ocular inflammatory conditions, including the use of systemic immunomodulatory therapy and the efficacy of various treatment modalities.

 

CanMEDS Roles: Medical Expert, Collaborator

Sub Sessions

13:30 - 13:50 | 20 minutos
Keynote SpeakerUveitis

Pinar Özdal, MD

Keynote speaker
13:50 - 14:00 | 10 minutos
14:00 - 14:05 | 5 minutos

 Authors: Daniel Lamoureux1, David Wong2, Tina Felfeli2. 1Northern Ontario School of Medicine, 2University of Toronto. Author Disclosures: D. Lamoureux: None. D. Wong: None. T. Felfeli: None. Abstract Body:&nb...

14:05 - 14:10 | 5 minutos

 Authors: Tina Felfeli1 Natalie Kozlowski2, Felicia Tai3, Jorge R. Georgakopoulos4, Elizabeth Uleryk, Rafael N. Miranda5, 6. 1Temerty Faculty of Medicine, University of Toronto, 2Division of Ophthalmology, McMaster University, 3University of Toronto, 4E/M Uleryk Consulting, 5Toronto Health Economics and Technolog...

14:10 - 14:15 | 5 minutos

 Authors: Raheem Remtulla , Karin M. Oliver. McGill University.Author Disclosures: R. Remtulla: None. K.M. Oliver: None. Abstract Body: Purpose: Immune checkpoint inhibitors (ICIs) inhibit the r...

14:15 - 14:20 | 5 minutos
14:20 - 14:25 | 5 minutos

 Authors: Christine E. Ashenhurst 1, Patrick Mitchell2, Michael Y. K. Mak3, Micheal T. Kryshtalskyj2.  1University of Victoria, 2University of Calgary, 3McGill University.Author Disclosures: C.E. Ashenhurst:   None.  P. Mitchell:  None. &n...

14:25 - 14:30 | 5 minutos

 Authors: Daniel Milad , Fares Antaki, Allison Bernstein, Samir Touma, Renaud Duval.  Université de Montréal.Author Disclosures: D. Milad:  None.  F. Antaki:    Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); ...

14:30 - 14:35 | 5 minutos

 Authors: Carol Tadrous , Steven Schendel, Kaivon Vaezi, Kulbir S. Gill, Mahadev Bhalla, Derek Chan, Claudio Perez. University of British Columbia. Author Disclosures: C. Tadrous: None. S. Schendel: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Abbvie, Alcon, Glaukos, Labtician, Thea, Bausch and Lomb. Any direct financial payments...

14:35 - 14:40 | 5 minutos
14:40 - 14:45 | 5 minutos

 Authors: Tina Felfeli1, Arshia Eshtiaghi2, Jess Rhee3, Michael Balas2, Felicia Tai4, Laurence A. Rubin5, Nupura K. Bakshi6, Larissa Derzko-Dzulynsky7. 1Department of Ophthalmology and Vision Sciences, University of Toronto; Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, 2The Temerty Faculty of Medicine, University...

14:45 - 14:50 | 5 minutos

 Authors: Mélanie Hébert1, Ryan Hendrick2, Keith Perry2, Mohammed Al-Kaabi3, Anna Polosa3, Marie-Josée Aubin3. 1Hôpital Saint-Sacrement, CHU de Québec - Université Laval, 2Université de Montréal, 3Centre universitaire d'ophtalmologie, Hôpital Maisonneuve-Rosemont.Author Disclosures: M. Hébert: Funded grants or clinical ...

14:50 - 14:55 | 5 minutos

 Authors: Keith Perry1, Mélanie Hébert2, Ryan Hendrick1, Mohammed Al Kaabi3, Anna Polosa3 Marie-Josée Aubin3. 1Université de Montréal, 2Hôpital Saint-Sacrement, CHU de Québec - Université Laval, 3Centre universitaire d'ophtalmologie, Hôpital Maisonneuve-Rosemont.Author Disclosures: K. Perry: None. M. Hébert...

14:55 - 15:00 | 5 minutos

My Session Status

Send Feedback